Guidance

Detection of gonorrhoea in England

Guidance on detecting gonorrhoea, including dual nucleic acid amplification tests (NAATs) for chlamydia and gonorrhoea.

• From: Public Health England
• Published: 13 August 2014
• Last updated: 26 March 2021 — See all updates

Documents

Guidance for the detection of gonorrhoea in England: updated 2021

Ref: PHE publications gateway number: GW-7753

PDF, 660 KB, 14 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This is an updated guidance for the detection of gonorrhoea in England, which was first published by Public Health England (PHE) in 2014.

The guidance aims to inform the commissioning and clinical delivery of gonorrhoea testing in England by recommending best practice. It highlights that in almost all settings the use of a supplementary NAAT is required to confirm the result, and the need to ensure effective and robust care pathways and management.

Published 13 August 2014

Last updated 26 March 2021 + show all updates

1. 26 March 2021

   Updated guidance for the detection of gonorrhoea in England.

2. 13 August 2014

   First published.